Interview Details

Title & Link

Watch CNBC's full interview with Gilead CEO Daniel O'Day

Publish Date

January 10, 2022

Interviewees

Daniel O'Day

Interviewers

Meg Tirrell

Publisher

CNBC

Topics

Covid-19 antiviral Remdesivir
inhaled version of the Covid-19 antiviral
oncology partnership with Merck
pill version

People Mentioned

Bryn Talkington
David Burritt
John Paulson
Mike Rode
Mohamed El-Erian

Works Mentioned

None found. Add this info

Places Mentioned

None found. Add this info


Let us know if there's something wrong or missing. Edit this interview